As researchers continue exploring early-intervention strategies for high-risk smoldering multiple myeloma, understanding the basic pathophysiology of plasma cell disorders (and the targets of emerging...
Ibrutinib, the first-generation Bruton tyrosine kinase inhibitor, has well-documented cardiovascular effects that influence treatment decisions for patients with chronic lymphocytic leukemia. This quiz...
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
Male breast cancer comprises 0.3% of all cancer in men, but men typically present with more advanced disease than women due to delayed care. This quick quiz will test your knowledge on male breast cancer...
Sexual and gender minority (SGM) patients as well as transgender and gender-diverse (TGD) patients historically face systemic barriers in healthcare. Gynecological cancer care must account for the unique...
How well do you understand the latest findings on fixed-duration acalabrutinib–venetoclax regimens in untreated chronic lymphocytic leukemia? Take this quiz to find out!
Colorectal cancer screening guidelines have shifted, but gaps in uptake remain—especially among younger and underserved populations. Test your knowledge of the current recommendations and key disparities in...
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
Endometrial cancer risk can be influenced by genetic, hormonal, and metabolic factors, and understanding which can be crucial to prevention and early detection. Do you know the risk factors for endometrial...
Esophageal squamous cell carcinoma (ESCC) and adenocarcinoma differ not only in their histology but also in risk factors and anatomical distribution. Test your understanding of where ESCC typically...
